Market and earnings impact on the pharmaceutical business from drug price revisions, healthcare system changes and pricing policy changes | Shared theme
ONE-WAYOngoing theme · still written in the latest filings
Market and earnings impact on the pharmaceutical business from drug price revisions, healthcare system changes and pricing policy changes
The risk that accelerated switching to generic drugs, drug price cuts, and overseas pressure to contain drug costs will reduce the growth rate of the pharmaceutical market and available profit opportunities.
Companies88How many companies write about this.
Threads104One company can carry more than one thread here.